These highlights do not include all the information needed to use TRYNGOLZA safely and effectively. See full prescribing information for TRYNGOLZA.

Feb 9, 2025 · Tryngolza package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

TRYNGOLZA® (olezarsen) is an FDA-approved treatment in adults with FCS as an adjunct to diet. See Safety & Full Prescribing Information.

5 days ago · Table of Contents Tryngolza Product Label The following document was submitted to the FDA by the labeler of this product Ionis Pharmaceuticals, Inc.. The document includes …

TEVIMBRA (tislelizumab-jsgr) injection is a sterile, preservative-free, clear to slightly opalescent, colorless to slightly yellow solution for intravenous use, supplied in single-dose vials.

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRYNGOLZA safely and effectively. See full prescribing information …

Jul 25, 2025 · Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Tryngolza have been included in the summary of …

Tislelizumab is approved in the EU for the treatment of ESCC, G/GEJ and three non-small cell lung cancer (NSCLC) indications. Tislelizumab is under regulatory review for extensive-stage …

Dosage modifications for TEVIMBRA for adverse reactions that require management different from these general guidelines are summarized in Table 2. Refer to the respective Prescribing …

Do not use TRYNGOLZA if: • you have had a serious allergic reaction to olezarsen or any of the ingredients in TRYNGOLZA. See the end of this Patient Information for a complete list of …